返回 Agenda
Session 9: Special Topics for Clinical Research (Continued)
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- Surrogate Endpoints
- Qualification of Drug Development Tools
- Foreign Clinical Trials
- Changes to the Investigational Drug
- Financial Disclosure by Clinical Investigators
- Special Protocol Assessment